Ivan Trifunović: From Biotech Leader to Serbia’s Envoy in Switzerland

Professionally, he began as a chemist in 1992 and later rose to senior roles at Johnson & Johnson and Pharmacia. He led WaferGen Bio-Systems as CEO through a NASDAQ IPO and orchestrated its acquisition by Takara Bio in 2017. As co‑founder and president of San Francisco–based Dren Bio, Trifunović guided the startup through early-phase success; notably, its DR‑0201 immunology therapy was acquired by Sanofi in a deal valued at €554 million
Dr. Ivan TrifunovićDealroom has a profile for this one. Try Dealroom →, a prominent figure in global biotechnology and pharmaceuticals, has embarked on a new chapter as Serbia’s Ambassador to the Swiss Confederation. With an illustrious career marked by high-stakes leadership and innovation, Trifunović brings a rich blend of academic excellence, corporate achievement, and international diplomacy to his diplomatic role.

As a member of the advisory board for Pupin Initiative, Trifunović has contributed to Serbia’s flagship BIO4 initiative—a €450 million biotech campus built to revitalize domestic research, attract diaspora talent, and strengthen Western partnerships.

Appointed ambassador in April 2025, he was formally interviewed by Serbia’s Foreign Affairs Committee on 15 May before assuming duties in Switzerland. His mandate aims to deepen bilateral ties, foster economic investment, especially in high-tech and pharmaceutical sectors, and enhance diaspora connections through education, science, and culture .

Beyond his professional roles, Trifunović actively supports scientific and youth programs in Serbia and the U.S. through his family foundation. Passionate about photography and skiing, he is well-positioned to engage both Serbian communities in Switzerland and his adopted home’s local culture.

In appointing a biotech pioneer as ambassador, Serbia underscores its ambition to blend scientific innovation with diplomatic outreach—placing Trifunović at the heart of modernizing Serbia’s international presence while building bridges into Switzerland’s research and industrial ecosystem.

Source : Pupin Initiative &Serbinfo
D.D.